| 1 |
33105932 | [Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway]. | 2020 Oct 20 |
1 |
| 2 |
27595938 | Effects of ligand binding on the stability of aldo-keto reductases: Implications for stabilizer or destabilizer chaperones. | 2016 Dec |
2 |
| 3 |
25376835 | Reduction of lipid peroxidation products and advanced glycation end-product precursors by cyanobacterial aldo-keto reductase AKR3G1—a founding member of the AKR3G subfamily. | 2015 Jan |
1 |
| 4 |
24598757 | Identification of a novel polyfluorinated compound as a lead to inhibit the human enzymes aldose reductase and AKR1B10: structure determination of both ternary complexes and implications for drug design. | 2014 Mar |
1 |
| 5 |
23295227 | X-ray structure of the V301L aldo-keto reductase 1B10 complexed with NADP(+) and the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity. | 2013 Feb 25 |
1 |
| 6 |
22319498 | Aldo-Keto Reductase 1B10 and Its Role in Proliferation Capacity of Drug-Resistant Cancers. | 2012 |
1 |
| 7 |
20460771 | Selective inhibition of the tumor marker AKR1B10 by antiinflammatory N-phenylanthranilic acids and glycyrrhetic acid. | 2010 |
2 |
| 8 |
19013440 | Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes. | 2009 Mar 16 |
5 |
| 9 |
19028477 | Cancer biomarker AKR1B10 and carbonyl metabolism. | 2009 Mar 16 |
2 |
| 10 |
19706287 | Potent and selective inhibition of the tumor marker AKR1B10 by bisdemethoxycurcumin: probing the active site of the enzyme with molecular modeling and site-directed mutagenesis. | 2009 Nov 6 |
1 |
| 11 |
18087047 | Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10. | 2007 Dec 26 |
1 |
| 12 |
16381663 | Purification and characterization of akr1b10 from human liver: role in carbonyl reduction of xenobiotics. | 2006 Mar |
1 |